Acción 301126 HUNAN DAJIAWEIKANG PHARMACEUTICAL INDUSTRY CO.,LTD
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd

Acciones

301126

CNE1000054V3

Precio de cierre Shenzhen S.E.
Otros sitios de cotización
 00:00:00 21/06/2024 		Varia. Cinco días. Varia. 1 de enero.
8,93 CNY +0,56 % Gráfico intradía de Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd -1,22 % -31,47 %
05/06 Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd (SZSE:301126) inicia una recompra de acciones por valor de 15 millones de CNY, en virtud de la autorización aprobada el 15 de abril de 2024. CI
22/04 Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd comunica los resultados de beneficios del primer trimestre finalizado el 31 de marzo de 2024 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!
Inscripción 100% Gratuita
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd commences an Equity Buyback for CNY 15 million worth of its shares, under the authorization approved on April 15, 2024.
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 29 May 2024
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Approves Cash Dividend for 2023
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd announced that it expects to receive CNY 119.999994 million in funding
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Approves Board Elections
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd signed the share acquisition agreement to acquire 51% stake in Shanxi Simaile Pharmaceutical Chain Co., Ltd. from Yang Jinjiang, Liu Hongming for approximately CNY 330 million.
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd agreed to acquire Yinchuan Meihetai Pharmaceutical Chain Co., Ltd. from Xie Huiyang and Xie Xiaolong for approximately CNY 250 million.
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Implements Final Cash Dividend of A Shares for the Year 2022, Payable on June 12, 2023
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Approves Final Cash Dividend for 2022
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd cancelled the transaction announced on May 18, 2022
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd announced that it expects to receive CNY 300 million in funding
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Proposes Final Cash Dividend for the Year 2022
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
Hunan Tongjian Pharmacy to Buy 86% Stake in Local Peer For 341 Million Yuan
Hunan Tongjian Pharma to Buy 86% of Local TCM Maker For 341 Million Yuan
Certain A Shares of Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd. are subject to a Lock-Up Agreement Ending on 8-DEC-2022.
Hunan Dajiaweikang Pharma to Buy 85.7% Stake in Pharma Firm
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción 301126
  4. Noticias Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd
  5. Otros idiomas